Lead sponsor
Amylyx Pharmaceuticals Inc.
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
2
Trials led
1
Ongoing
75
Total enrollment
22
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Not applicable
1
Trials by status
Active, not recruiting
1
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric HypoglycemiaBMI ≤40not applicableUnknownnot disclosed